Cargando…
Risk factors for nephropathy in persons with type 1 diabetes: a population-based study
AIMS: Albuminuria is strongly associated with risk of renal dysfunction, cardiovascular disease and mortality. However, clinical guidelines diverge, and evidence is sparse on what risk factor levels regarding blood pressure, blood lipids and BMI are needed to prevent albuminuria in adolescents and y...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085666/ https://www.ncbi.nlm.nih.gov/pubmed/35201418 http://dx.doi.org/10.1007/s00592-022-01863-6 |
_version_ | 1784703867950202880 |
---|---|
author | Seyed Ahmadi, Shilan Pivodic, Aldina Svensson, Ann-Marie Wedel, Hans Rathsman, Björn Nyström, Thomas Ludvigsson, Johnny Lind, Marcus |
author_facet | Seyed Ahmadi, Shilan Pivodic, Aldina Svensson, Ann-Marie Wedel, Hans Rathsman, Björn Nyström, Thomas Ludvigsson, Johnny Lind, Marcus |
author_sort | Seyed Ahmadi, Shilan |
collection | PubMed |
description | AIMS: Albuminuria is strongly associated with risk of renal dysfunction, cardiovascular disease and mortality. However, clinical guidelines diverge, and evidence is sparse on what risk factor levels regarding blood pressure, blood lipids and BMI are needed to prevent albuminuria in adolescents and young adults with type 1 diabetes. METHODS: A total of 9347 children and adults with type 1 diabetes [mean age 15.3 years and mean diabetes duration 1.4 years at start of follow-up] from The Swedish National Diabetes Registry were followed from first registration until end of 2017. Levels for risk factors for a risk increase in nephropathy were evaluated, and the gradient of risk per 1 SD (standard deviation) was estimated to compare the impact of each risk factor. RESULTS: During the follow-up period, 8610 (92.1%) remained normoalbuminuric, 737 (7.9%) individuals developed micro- or macroalbuminuria at any time period of whom 132 (17.9% of 737) individuals developed macroalbuminuria. Blood pressure ≥ 140/80 mmHg was associated with increased risk of albuminuria (p ≤ 0.0001), as were triglycerides ≥ 1.0 mmol/L (p = 0.039), total cholesterol ≥ 5.0 mmol/L (p = 0.0003), HDL < 1.0 mmol/L (p = 0.013), LDL 3.5– < 4.0 mmol/L (p = 0.020), and BMI ≥ 30 kg/m(2) (p = 0.033). HbA1c was the strongest risk factor for any albuminuria estimated by the measure gradient of risk per 1 SD, followed by diastolic blood pressure, triglycerides, systolic blood pressure, cholesterol and LDL. In patients with HbA1c > 65 mmol/mol (> 8.1%), blood pressure > 140/70 mmHg was associated with increased risk of albuminuria. CONCLUSIONS: Preventing renal complications in adolescents and young adults with type 1 diabetes need avoidance at relatively high levels of blood pressure, blood lipids and BMI, whereas very tight control is not associated with further risk reduction. For patients with long-term poor glycaemic control, stricter blood pressure control is advocated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01863-6. |
format | Online Article Text |
id | pubmed-9085666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-90856662022-05-11 Risk factors for nephropathy in persons with type 1 diabetes: a population-based study Seyed Ahmadi, Shilan Pivodic, Aldina Svensson, Ann-Marie Wedel, Hans Rathsman, Björn Nyström, Thomas Ludvigsson, Johnny Lind, Marcus Acta Diabetol Original Article AIMS: Albuminuria is strongly associated with risk of renal dysfunction, cardiovascular disease and mortality. However, clinical guidelines diverge, and evidence is sparse on what risk factor levels regarding blood pressure, blood lipids and BMI are needed to prevent albuminuria in adolescents and young adults with type 1 diabetes. METHODS: A total of 9347 children and adults with type 1 diabetes [mean age 15.3 years and mean diabetes duration 1.4 years at start of follow-up] from The Swedish National Diabetes Registry were followed from first registration until end of 2017. Levels for risk factors for a risk increase in nephropathy were evaluated, and the gradient of risk per 1 SD (standard deviation) was estimated to compare the impact of each risk factor. RESULTS: During the follow-up period, 8610 (92.1%) remained normoalbuminuric, 737 (7.9%) individuals developed micro- or macroalbuminuria at any time period of whom 132 (17.9% of 737) individuals developed macroalbuminuria. Blood pressure ≥ 140/80 mmHg was associated with increased risk of albuminuria (p ≤ 0.0001), as were triglycerides ≥ 1.0 mmol/L (p = 0.039), total cholesterol ≥ 5.0 mmol/L (p = 0.0003), HDL < 1.0 mmol/L (p = 0.013), LDL 3.5– < 4.0 mmol/L (p = 0.020), and BMI ≥ 30 kg/m(2) (p = 0.033). HbA1c was the strongest risk factor for any albuminuria estimated by the measure gradient of risk per 1 SD, followed by diastolic blood pressure, triglycerides, systolic blood pressure, cholesterol and LDL. In patients with HbA1c > 65 mmol/mol (> 8.1%), blood pressure > 140/70 mmHg was associated with increased risk of albuminuria. CONCLUSIONS: Preventing renal complications in adolescents and young adults with type 1 diabetes need avoidance at relatively high levels of blood pressure, blood lipids and BMI, whereas very tight control is not associated with further risk reduction. For patients with long-term poor glycaemic control, stricter blood pressure control is advocated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01863-6. Springer Milan 2022-02-24 2022 /pmc/articles/PMC9085666/ /pubmed/35201418 http://dx.doi.org/10.1007/s00592-022-01863-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Seyed Ahmadi, Shilan Pivodic, Aldina Svensson, Ann-Marie Wedel, Hans Rathsman, Björn Nyström, Thomas Ludvigsson, Johnny Lind, Marcus Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title | Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title_full | Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title_fullStr | Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title_full_unstemmed | Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title_short | Risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
title_sort | risk factors for nephropathy in persons with type 1 diabetes: a population-based study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085666/ https://www.ncbi.nlm.nih.gov/pubmed/35201418 http://dx.doi.org/10.1007/s00592-022-01863-6 |
work_keys_str_mv | AT seyedahmadishilan riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT pivodicaldina riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT svenssonannmarie riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT wedelhans riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT rathsmanbjorn riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT nystromthomas riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT ludvigssonjohnny riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy AT lindmarcus riskfactorsfornephropathyinpersonswithtype1diabetesapopulationbasedstudy |